« Back
Home /
Tigatuzumab Biosimilar (Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody)

Tigatuzumab Biosimilar (Anti-TNFRSF10B / TRAILR2 / CD262 Reference Antibody)

Item no.	DCC-A950-100mg
Manufacturer	DCChemicals
CASRN	918127-53-4
Amount	100 mg
Category	In Vivo
Applications	IV
Specific against	other
Available
Manufacturer - Applications	Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). Tigatuzumab induces cell apoptosis of cancer cells and inhibits tumor growth in vivo. Tigatuzumab can be used for the research of cancer.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time